Cannabis Use, Public Health, and Traffic Safety: Outcomes from the Scientific Literature and Expert Opinion on the Potential Impacts of Rescheduling

Cannabis is currently a Schedule I controlled substance under the Federal Comprehensive Drug Abuse Prevention and Control Act. The Drug Enforcement Administration has an ongoing process to consider moving cannabis to a Schedule III drug, thereby reducing the associated penalties. Arguments have been made in recent years inviting public support for rescheduling and legalization of cannabis in the United States. In 2017, a committee of experts gathered by the National Academies of Sciences, Engineering, and Medicine (NASEM) concluded that there was a lack of scientific research regarding the health effects of using cannabis and cannabis-derived products. Much more modest in scope, the current report endeavors to provide a picture of the current state of scientific knowledge on the impact of cannabis use as it is associated with the factors established by the Controlled Substances Act for drug scheduling. This report included two main tasks. Part I offers a detailed review of the literature, including a description of the approach used to build the review; a brief portrayal of the biological mechanisms by which cannabis components affect (or could affect) human health and behavior; and a summary of findings with references. Additionally, key takeaways are presented in nonacademic layman terms. Part II involved focus groups with subject matter experts, who shared their opinion on the potential impacts of cannabis rescheduling on public health and traffic safety.

Language

  • English

Media Info

  • Media Type: Digital/other
  • Features: Appendices; Figures; References; Tables;
  • Pagination: 95p

Subject/Index Terms

Filing Info

  • Accession Number: 01942837
  • Record Type: Publication
  • Files: TRIS
  • Created Date: Jan 21 2025 9:16AM